unknown
Stage
2010
Founded
2
Investors
About
CEVEC Pharmaceuticals GmbH develops and provides proprietary cell line technologies, such as CAP®GT and ELEVATE® expression systems, for the efficient and safe manufacturing of gene therapy vectors, vaccines, and recombinant proteins. These advanced platforms serve the biopharmaceutical industry to improve biologics production.
Explore CEVEC Pharmaceuticals GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.